AdeTherapeutics is a specialty pharma company based in Saskatoon, Saskatchewan, focused on providing quality therapeutic options in inflammation and acute care medicine.
AdeTherapeutics president and CEO Sanj Singh said that the partnership with Dalton is a key part of AdeTherapeutics capital efficient virtual drug development model where they work with expert service providers from all over the globe to bring their novel therapeutics and diagnostics forward benefiting the healthcare community with safe, reliable and cost-effective treatment choices.